Ainos Inc (AIMD)
Ainos, Inc. is a NASDAQ-listed common stock company focused on a dual platform spanning AI and biotech. Through its SmellTech efforts, the company is developing the AI Nose platform, which uses a smell language model to convert scent into Smell IDs and translate chemical signals into machine-readable data. Ainos also applies AI in areas such as robotics, smart factories, senior care, and women’s health. In biotechnology, it develops VELDONA, a low-dose oral interferon candidate being studied for rare, autoimmune, and infectious diseases, with additional applications in animal health. Formerly known as Amarillo Biosciences, Inc., the company adopted the Ainos name in May 2021. Incorporated in 1984, it is based in San Diego, California, and operates as a subsidiary of Taiwan Carbon Nano Technology Corporation.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-AIMD
|
$1.84
|
13.1% Upside
|
Fair
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
August 12, 2026
|
-0.9x
|
2.1x
|
660.8x
|
11.71 M
|
22.939 M
|
54.1%
|
32.4%
|
-36.0
|
—
|
31.4%
|
